ThermoGenesis Holdings (NASDAQ: THMO)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.020 | -0.160 | -0.1800 | ||||
REV | 5.600M | 2.663M | -2.937M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of ThermoGenesis Holdings (NASDAQ: THMO) through any online brokerage.
Other companies in ThermoGenesis Holdings’s space includes: NeuroOne Medical Tech (NASDAQ:NMTC), Viveve Medical (NASDAQ:VIVE), Nuwellis (NASDAQ:NUWE), InVivo Therapeutics Hldg (NASDAQ:NVIV) and GBS (NASDAQ:GBS).
The latest price target for ThermoGenesis Holdings (NASDAQ: THMO) was reported by HC Wainwright & Co. on Friday, November 13, 2020. The analyst firm set a price target for 8.50 expecting THMO to rise to within 12 months (a possible 3546.50% upside). 0 analyst firms have reported ratings in the last year.
The stock price for ThermoGenesis Holdings (NASDAQ: THMO) is $0.2331 last updated Today at July 1, 2022, 4:57 PM UTC.
There are no upcoming dividends for ThermoGenesis Holdings.
ThermoGenesis Holdings’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for ThermoGenesis Holdings.
ThermoGenesis Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.